Effects of extracellular nucleotides on single cells and populations of human osteoblasts: Contribution of cell heterogeneity to relative potencies

British Journal of Pharmacology

Volumn 120, Issue 5, 1997, Pages 777-780

  Dixon, C Jane ^a   Bowler, Wayne B ^a   Walsh, Catherine A ^a   Gallagher, James A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

2 meSATP; ADP; ATP; Cytosolic free calcium concentration; Heterogeneity; Human osteoblasts; P2 receptors; UTP

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIUM ION; NUCLEOTIDE; PURINE P2 RECEPTOR;

ARTICLE; CALCIUM CELL LEVEL; CELL HETEROGENEITY; CELL POPULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL;

ADENINE NUCLEOTIDES; CALCIUM; CELLS, CULTURED; HUMANS; OSTEOBLASTS; RECEPTORS, PURINERGIC P2; URIDINE TRIPHOSPHATE;

EID: 0030935946     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0700961     Document Type: Article

References (24)

1. ABBRACCHIO, M.P. & BURNSTOCK, G. (1994). Purinoceptors: Are there families of P2X and P2Y purinoceptors? Pharmacol. Ther., 64,445-475.
2. 2 purinoceptors: from molecular biology to functional responses. Trends Pharmacol. Sci., 16, 133-139.
3. BOWLER, W.B., BIRCH, M.A., GALLAGHER, J.A. & BILBE, G. (1995). Identification and cloning of human P2u purinoceptor present in osteoclastoma, bone, and osteoblasts. J. Bone Min. Res., 10, 1137-1145.
4. BOWLER, W.B., DIXON, C.J., HALLEUX, C, HIPSKIND, R.A., FRASER, W.D., BILBE, G. & GALLAGHER, J.A. (1996). A functional role for extracellular nucleotides in bone remodelling. Drug Dev. Res., 37, 181.
5. CRACK, B.E., POLLARD, C.E., BEUKERS, M.W., ROBERTS, S.M., HUNT, S.F., INGALL, A.H., McKECHNIE, K.C.W., IJZERMAN, A.P. & LEFF.P. (1995). Pharmacological analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br. J. Pharmacol., 114, 475-481.
6. 2+-mobilizing purinoceptors on rat hepatocytes. Biochem. J., 269, 499-502.
7. DUBYAK, G.R., MARTIN, K.A., HUMPHREYS, B.D. & CLIFFORD, E.E. (1996). Expression of multiple ATP receptor-based signalling cascades during development and inflammatory activation of human mononuclear phagocytes. Drug Dev. Res., 37, 110.
8. ERB, L., GARRAD, R., WANG, Y., QUINN, T., TURNER, J.T. & WEISMAN, G.A. (1995). Site-directed mutagenesis of P2U purinoceptors. J. Biol. Client., 270, 4185-4188.
9. EXTON, J.H. (1987). Calcium signalling in cells - molecular mechanisms. Kidney Inl., 32, S68-S76.
10. GALLAGHER, J.A., GUNDLE, R. & BERESFORD, J.N. (1996). Isolation and culture of bone-forming cells (osteoblasts) from human bone. In Methods in Molecular Biology, Vol.XX: Human Cell Culture Protocols, ed. Jones, G.H. pp. 233-262. Towata, N.J: Humana Press Inc.
11. GALLINARO, B.J. REIMER, W.J. & DIXON, S.J. (1995). Activation of protein kinase C inhibits ATP-induced [Ca2 + ]; elevation in rat osteoblastic cells: selective effects on P2y and P2u signalling pathways. J. Cell Physio!., 162, 305-314.
12. GRYNKIEWICZ, G., POENIE, M. & TSIEN, R.Y. (1985). A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3440-3450.
13. HARDEN, T.K., BOYER, J.L. & NICHOLAS, R.A. (1995). P2-purinergic receptors: Subtype-associated signalling responses and structure. Ann. Rev. Pharmacol. Toxicol., 35, 541-579.
14. JOHNSON, R.S., SPIEGELMAN, B.M. & PAPAIOANNOU, V. (1992). Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell, 71, 577-586.
15. 2x purinoceptors be classified pharmacologically. Trends Pharmacol. Sei., 16, 168-174.
16. KEPPENS, S., VANOEKERCKHOVE, A. & DE WULF, H. (1993). Characterization of the effects of adenosine 5′-[β-thioI]-diphosphate in rat liver. Br. J. Pharmacol., 108, 663-668.
17. KUMAGAI, H., SACKTOR, B. & FILBURN, C.R. (1991). Purinergic regulation of cytosolic calcium and phosphoinositide metabolism in rat osteoblast-like osteosarcoma cells. J. Bone Min. Res., 6, 697-707.
18. KUMAGAI, H., SAKAMOTO, H., GUGG1NO, S., FILBURN, C.R. & SACKTOR, B. (1989). Neurotransmitter regulation of cytosolic calcium in osteoblast-like bone cells. Calcif. Tiss. Int., 45, 251254.
19. O'CONNOR, S.E., DAINTY, I.A. & LEFF, P. (1991). Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol. Sei., 12, 137-141.
20. REIMER, W.J. & DIXON, S.J. (1992). Extracellular nucleotides elevate [Ca2 + ]i in rat osteoblastic cells by interaction with two receptor subtypes. Am. J. Physiol., 263, C1040-C1048.
21. SCHOFL, C., CUTHBERTSON, K.S.R., WALSH, C.A., MAYNE, C., COBBOLD, P., VON ZUR MÜHLEN, A., HESCH, R.-D. & GALLAGHER, J.A. (1992). Evidence for P2-purinoceptors on human osteoblast-like cells. J. Bone Miner. Res., 7, 485-491.
22. THOMAS, A.P. & DELAVILLE, F. (1991). The use of fluorescent indicators for measurements of cytosolic-free calcium concentration in cell populations and single cells. In Techniques in Calcium Research, ed. McCormack, J.G. & Cobbold, P.H. pp. 1-54. Oxford: I.R.L. Press.
23. YU, H. & FERRIER, J. (1993). Osteoblast-like cells have a variable mixed population of purino/nucleotide receptors. FEBS Lett., 328,209-214.
24. ZHENG, J., BOLUYT, M.O., O'NEIL, L.O., CROW, M.T. & LAKATTA, E.G. (1994). Extracellular ATP induces immediate early gene expression but not cellular hypertrophy in neonatal cardiac myocytes. Circ. Res., 74, 1034-1041.